Member Info for Timster

Tech Transfer with Abingdon will be announced in that 18 days (maybe)! thank feck for that!

The Company has made recent progress in relation to two projects involving scale-up and technical transfer to manufacture. Avacta plc's AffiDX® SARS-CoV-2 antigen lateral flow test is being validated to allow commercial product to be manufactured and released by Abingdon Health. Avacta have indicated that they may require the Company to produce between one and two million tests per month. The transfer process, which involves scale-up of processes and manufacture of three production-scale manufacturing runs, is progressing well and due for completion in this calendar year. A significant order for post-technical transfer production has been received from Avacta.

I think in the epic phone call with Medusa that was reported here. There was mention of having to send more information.

its a template for the photoshop Meduflow version, in progress as we speak :)

got your Q's mixed up there I think PK could have been Q4 2021 but more likely Q1 2022

the sauces are tingling....

Very interesting Monkshood

If I am reading that right could it mean that some of the lft's may not detect as they will be using the antibody that does not bind?

someone knows something...

Does indeed, once this fleckin HUA is granted they will swing into full marketing mode and Affidx will be all over the place (or Meduflow)....

still no one answering the phone to me though :(

thought it was AVA3996 pro-velcade up next, target selected by year end so our glorious leader says.

https://youtu.be/NZHIxNQT4Tg?t=1390

Only 30 quid a share!!! You're having a laugh :)

America has its own large domestic manufactures just look at michael Mina tweets. They also have much cheaper just a bare strip tests.

although it would be great to get some sales in the US I dont think there is any chance Avacta will be bought for its LFT. The Cancer pipeline is very likely to attract big pharma though.

PCR seems to be priority

https://clinical.r-biopharm.com/news/coronavirus-test-kit-receives-ce-label/

https://www.gov.uk/government/publications/covid-19-test-validation-approved-products#history

At least it's Scottish and not Chinese

Lateral flow tests, quick email in!

says only variants of concern will be tested and Gamma (brazil) was one

https://www.ecdc.europa.eu/en/covid-19/variants-concern

Appolgies, it is daewoong taking this forward
https://avacta.com/innovations-in-neutralising-therapies/

Approved by the mhra
https://www.gov.uk/government/news/mhra-approves-xevudy-sotrovimab-a-covid-19-treatment-found-to-cut-hospitalisation-and-death-by-79

We've got an affimer that does that, unfortunately didn't get further than identifying it.

we should get some samples at some point:

Avacta® Diagnostics monitors the emergence of new SARS-CoV-2 Variants of Concern (VOC) using the Public Health England (PHE) and World Health Organisation (WHO) lists. A Variant of Concern is one that has been shown to be associated with one or more of the following changes:

Increase in transmissibility or detrimental change in COVID-19 epidemiology
Increase in virulence or change in clinical disease presentation
Decrease in effectiveness of public health and social measures or available diagnostics, vaccines, therapeutics.
When a variant is designated as a VOC, Avacta® obtains the irradiated virus, when it becomes available, and tests it on the AffiDX® SARS-CoV-2 Antigen Lateral Flow Test.

sounds very promising, pre|CISION™ will be worth billions to Avacta..

nothing added today, I've got it open in the background
https://www.gov.uk/government/publications/covid-19-test-validation-approved-products#history

the desktop review team are flat out clearly.....